Similar articles

• Lowered brain stimulation reward thresholds in rats treated with a combination of caffeine and N-methyl-D-aspartate but not alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate or metabotropic glutamate receptor-5 receptor antagonists.

  Bespalov A, Dravolina O, Belozertseva I, Adamcio B, Zvartau E. Bespalov A, et al. Behav Pharmacol. 2006 Jun;17(4):295-302. doi: 10.1097/01.fbp.0000205014.67079.be. Behav Pharmacol. 2006. PMID: 16914947
• Investigation of the antidyskinetic site of action of metabotropic and ionotropic glutamate receptor antagonists. Intracerebral infusions in 6-hydroxydopamine-lesioned rats with levodopa-induced dyskinesia.

  Maranis S, Stamatis D, Tsironis C, Konitsiotis S. Maranis S, et al. Eur J Pharmacol. 2012 May 15;683(1-3):71-7. doi: 10.1016/j.ejphar.2012.02.036. Epub 2012 Mar 4. Eur J Pharmacol. 2012. PMID: 22410193
• Glutamate as a therapeutic target in psychiatric disorders.

  Javitt DC. Javitt DC. Mol Psychiatry. 2004 Nov;9(11):984-97, 979. doi: 10.1038/sj.mp.4001551. Mol Psychiatry. 2004. PMID: 15278097 Review.
• Prolonged blockade of NMDA or mGluR5 glutamate receptors reduces nigrostriatal degeneration while inducing selective metabolic changes in the basal ganglia circuitry in a rodent model of Parkinson's disease.

  Armentero MT, Fancellu R, Nappi G, Bramanti P, Blandini F. Armentero MT, et al. Neurobiol Dis. 2006 Apr;22(1):1-9. doi: 10.1016/j.nbd.2005.09.010. Epub 2005 Nov 11. Neurobiol Dis. 2006. PMID: 16289868
• [Modern aspects of investigation and clinical application of glutamatergic agents].

  Petrov VI, Onishchenko NV. Petrov VI, et al. Eksp Klin Farmakol. 2002 Jul-Aug;65(4):66-70. Eksp Klin Farmakol. 2002. PMID: 12449079 Review. Russian.